{
    "clinical_study": {
        "@rank": "50187", 
        "arm_group": [
            {
                "arm_group_label": "Malignant tumors", 
                "description": "Patients who have one of the Neoplasms stated above under \"conditions\"."
            }, 
            {
                "arm_group_label": "Benign controls", 
                "description": "Patients with a benign tumor or an inflammatory disease - to be matched by age."
            }, 
            {
                "arm_group_label": "Healthy controls", 
                "description": "People/patients who have no known disease at time of sampling or are admitted to the hospital for minor interventions and have no inflammatory disease."
            }
        ], 
        "biospec_descr": {
            "textblock": "Universal tumor bank"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Establishment of a tumor bank, consisting of tissue samples of tumor patients (benign and\n      malign tumors) and healthy people as controls. The tissue samples will be collected\n      systematically together with the corresponding clinical data. The biological samples, the\n      clinical date together with prospective experimental date constitute the entity of the\n      tissue tumor bank.\n\n      This tumor bank for tissue samples, together with our tumorbank for blood samples\n      (NCT01763125) combined constitute the entity \"Tumorbank\"."
        }, 
        "brief_title": "Tumor Bank for Tissue Samples", 
        "completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ovarian Neoplasms", 
            "Breast Neoplasms", 
            "Colorectal Neoplasms", 
            "Neoplasms of the Female Genitalia", 
            "Lung Neoplasms", 
            "Endocrine Gland Neoplasms"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Neoplasms", 
                "Colorectal Neoplasms", 
                "Endocrine Gland Neoplasms", 
                "Lung Neoplasms", 
                "Ovarian Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Recent progress in diagnosis and therapy of cancer diseases can be ascribed mainly to\n      translational research. The relevance of \"translational oncology\" will only increase in the\n      future -\"From bench to bedside\" - the swift implementation of new science research results\n      in clinical studies in order to expedite progress in clinical cancer therapy for the benefit\n      of the patient.\n\n      Its almost a matter of course in the medical science today to collect biological samples\n      together with clinical information thereby creating the foundation for future excellent\n      fundamental research.\n\n      The aim of this tumor bank is to consist of biological samples (together with a blood bank -\n      see NCT01763125) and isolates of tumor patients and healthy people as controls. The\n      biological samples, the clinical date together with prospective experimental date constitute\n      the entity of the tumor bank. The content of the tumor bank can provide essential material\n      for current and future research (e.g. analyses of prognostic or predictive tumor markers;\n      genetically analysis (polymorphism, mutation, hypermethylation; verification and\n      characterisation of disseminated tumor cells)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male/Female\n\n          -  Age 18 to 90 years max.\n\n          -  Just one current known malignant disease or just one current inflammatory disease\n\n        Exclusion Criteria:\n\n          -  Inflammatory disease and malignant disease\n\n          -  multiple malignancies\n\n          -  multiple diseases\n\n          -  underage"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Male and female patients/people. Minimum age 18 years Characteristics: Recruited at the\n        Medical University Vienna or at one of the facilities cooperating with the Vienna Med.\n        University"
            }
        }, 
        "enrollment": {
            "#text": "10000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01789229", 
            "org_study_id": "EK 260/2003"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Malignant tumors", 
                    "Benign controls"
                ], 
                "description": "Tissue sample is collected during therapeutic intervention by a medical doctor/surgeon.\nFrozen tissue sections are first transferred to Dept.of Pathology. Pathologist samples required tissue to obtain enough evidence for analysis/diagnosis.\nRest tumor material with or without malignant cells is tranferred to the lab for Molecular Oncology of Prof.Zeillinger.", 
                "intervention_name": "Tumor tissue collection", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Malignant tumors", 
                    "Benign controls"
                ], 
                "description": "Samples of malignant ascites and/or malignant pleural effusion is only collected during therapeutic intervention from patients at inpatient care.", 
                "intervention_name": "Sampling of ascites and pleural effusion", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Malignant tumors", 
                    "Benign controls", 
                    "Healthy controls"
                ], 
                "description": "Patient is asked to give a urine sample. Urine is collected in urine beaker.", 
                "intervention_name": "Collecting urine samples", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Malignant tumors", 
                    "Benign controls", 
                    "Healthy controls"
                ], 
                "description": "Saliva sample is collected by spatula from the mouth cavity of the patient.", 
                "intervention_name": "Collecting saliva sample", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Malignant tumors", 
                    "Benign controls", 
                    "Healthy controls"
                ], 
                "description": "Patient is asked to produce sputum into a 50ml lab tube.", 
                "intervention_name": "Collecting sputum", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Malignant tumors", 
                    "Benign controls", 
                    "Healthy controls"
                ], 
                "description": "Stool samples are collected prior to bowel preparation for colonoscopy. Device for sampling is provided to the patient.", 
                "intervention_name": "Collecting stool samples", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Malignant tumors", 
                    "Benign controls", 
                    "Healthy controls"
                ], 
                "description": "Irrigation liquid is collected during routine therapeutic or diagnostic procedure, e.g. lavage of the uterine cavity during routine saline contrast hysterosonography of women scheduled for surgery.", 
                "intervention_name": "Lavage/Irrigation", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breast cancer", 
            "Ovarian cancer", 
            "Endometrium carcinoma", 
            "Cervix carcinoma,", 
            "Mamma carcinoma,", 
            "Prostata carcinoma", 
            "Colon carcinoma", 
            "Rectal carcinoma", 
            "Bronchus carcinoma", 
            "NSCLC (non small cell lung cancer) & SCLC (small cell lung cancer)", 
            "Prostate carcinoma"
        ], 
        "lastchanged_date": "November 14, 2013", 
        "link": {
            "description": "The Molecular Oncology Group of The Department of Obstetrics and Gynaecology at the Medical University of Vienna", 
            "url": "http://www.molonc.at/index.php"
        }, 
        "location": [
            {
                "contact": {
                    "email": "ignace.vergote@uzleuven.be", 
                    "last_name": "Ignace Vergote, Prof.Dr.", 
                    "phone": "+32/1634", 
                    "phone_ext": "4208"
                }, 
                "contact_backup": {
                    "email": "joke.deroover@uz.kuleuven.ac.be", 
                    "last_name": "Joke de Roover", 
                    "phone": "+32 16 34", 
                    "phone_ext": "74 19"
                }, 
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "3000"
                    }, 
                    "name": "University Hospitals Leuven - Department of Obstetrics and Gynaecology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Jalid.Sehouli@charite.de", 
                    "last_name": "Jalid Sehouli, Prof.Dr."
                }, 
                "contact_backup": {
                    "email": "ioana@braicu.de", 
                    "last_name": "Ioana Braicu, Dr.", 
                    "phone": "+49 30 450 564", 
                    "phone_ext": "002"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Charit\u00e9 University - Campus Virchow Chlinic"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Germany"
            ]
        }, 
        "number_of_groups": "3", 
        "official_title": "Establishment of a Tissue Sample Bank in the Field of Gynaecological Oncology", 
        "overall_contact": {
            "email": "robert.zeillinger@meduniwien.ac.at", 
            "last_name": "Robert Zeillinger, Prof.Dr.", 
            "phone": "+43140400", 
            "phone_ext": "7831"
        }, 
        "overall_contact_backup": {
            "email": "nina.pecha@meduniwien.ac.at", 
            "last_name": "Nina M Pecha", 
            "phone": "+4340400", 
            "phone_ext": "2784"
        }, 
        "overall_official": {
            "affiliation": "Medical University of Vienna, Dptm. of Obstetrics & Gynaecology", 
            "last_name": "Robert Zeillinger, Prof.Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Austria: Ethikkommission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Establishment of blood/tissue bank consisting of oncological samples from cancer patients and benign and healthy controls.", 
            "safety_issue": "No", 
            "time_frame": "14 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01789229"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Vienna", 
            "investigator_full_name": "Univ.Prof.Dr. Robert Zeillinger", 
            "investigator_title": "Univ.Prof. Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "20101229", 
                "citation": "Hofstetter G, Berger A, Fiegl H, Slade N, Zori\u0107 A, Holzer B, Schuster E, Mobus VJ, Reimer D, Daxenbichler G, Marth C, Zeimet AG, Concin N, Zeillinger R. Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer. Oncogene. 2010 Apr 1;29(13):1997-2004. doi: 10.1038/onc.2009.482. Epub 2010 Jan 18."
            }, 
            {
                "PMID": "21159173", 
                "citation": "Tong D, Heinze G, Pils D, Wolf A, Singer CF, Concin N, Hofstetter G, Schiebel I, Rudas M, Zeillinger R. Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients. BMC Cancer. 2010 Dec 15;10:682. doi: 10.1186/1471-2407-10-682."
            }, 
            {
                "PMID": "21376376", 
                "citation": "Grimm C, Watrowski R, Baum\u00fchlner K, Natter C, Tong D, Wolf A, Zeillinger R, Leodolter S, Reinthaller A, Hefler L. Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia. Gynecol Oncol. 2011 Jun 1;121(3):537-41. doi: 10.1016/j.ygyno.2011.02.019. Epub 2011 Mar 3."
            }, 
            {
                "PMID": "22009029", 
                "citation": "Hofstetter G, Berger A, Schuster E, Wolf A, Hager G, Vergote I, Cadron I, Sehouli J, Braicu EI, Mahner S, Speiser P, Marth C, Zeimet AG, Ulmer H, Zeillinger R, Concin N. \u0394133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer. Br J Cancer. 2011 Nov 8;105(10):1593-9. doi: 10.1038/bjc.2011.433. Epub 2011 Oct 18."
            }, 
            {
                "PMID": "23096450", 
                "citation": "Pils D, Horak P, Vanhara P, Anees M, Petz M, Alfanz A, Gugerell A, Wittinger M, Gleiss A, Auner V, Tong D, Zeillinger R, Braicu EI, Sehouli J, Krainer M. Methylation status of TUSC3 is a prognostic factor in ovarian cancer. Cancer. 2012 Oct 23. doi: 10.1002/cncr.27850. [Epub ahead of print]"
            }
        ], 
        "source": "Medical University of Vienna", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical University of Vienna", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2003", 
        "study_design": "Observational Model: Case Control", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}